LXRX vs CRIS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

LXRX

70.0
AI Score
VS
LXRX Wins

CRIS

52.3
AI Score

Investment Advisor Scores

LXRX

70score
Recommendation
HOLD

CRIS

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LXRX CRIS Winner
Forward P/E 0 0 Tie
PEG Ratio -0.14 0 Tie
Revenue Growth -97.6% -66.0% CRIS
Earnings Growth -63.4% 0.0% CRIS
Tradestie Score 70.0/100 52.3/100 LXRX
Profit Margin -147.4% 0.0% CRIS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LXRX 1M: -18.8% · 3M: -21.6% CRIS 1M: -41.8% · 3M: -86.5%

Current Technical Phase

LXRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.5%), weak momentum, RSI 35

RSI (14): 34.8 · Price: $1.82

CRIS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -32.4%), weak momentum, RSI 23

RSI (14): 23.0 · Price: $0.80

Fundamentals Snapshot

Metric LXRX CRIS
Market Cap — —
Forward P/E -9.6 -0.1
Trailing P/E — 0.2
Revenue (TTM) — —
Revenue Growth -1.0% -0.7%
Gross Margin 0.9% -4.9%
Operating Margin -38.4% -8.3%
EPS -0.16 3.65
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.